SK bioscience eagerly awaits final approvals for Covid vaccine

2022-08-26 08:42:43 By : Ms. Jessica Liang

An SK bioscience researcher checks SKYCovione Covid-19 vaccine vials at L House, the company’s vaccine manufacturing facility in Andong, North Gyeongsang. [SK BIOSCIENCE]

SKYCovione vials are lined-up at L House. [SK BIOSCIENCE]

A researcher holds a box of SKYCovione vials. A box holds 10 vials, which could be administrated to 100 people. [SK BIOSCIENCE]

An SK bioscience researcher checks the quality of SKYCovione Covid-19 vaccine at L House. [SK BIOSCIENCE]

L House, SK Bioscience's manufacturing plant in Andong, North Gyeongsang [SK BIOSCIENCE]

Posco Holdings completes construction of battery recycling plant in Poland

Samsung's Galaxy Z Flip 4 and Z Fold 4 available in 40 countries

Singapore-based ecommerce firm Qoo10 to acquire TMON

Merck Award and Merck Young Scientists Award announced

SK bioscience's GBP510 one step closer to being country's first vaccine

SK Bioscience has new goals for its Covid vaccine

SK bioscience to speed up global distribution of its Covid-19 vaccine

Approval requested for Korea's first Covid vaccine

SK Bioscience re-ups to supply vaccine manufacturing capacity to CEPI

To write comments, please log in to one of the accounts.

All materials contained on this site are protected by Korean copyright law and may not be reproduced, distributed, transmitted, displayed, published or broadcast without the prior consent of Joins.com | Tel: 1577-0510